CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Strong product pipeline & rapidly growing geriatric population
4.1.2. Increased risk of CAD and PAD in the elderly population
4.1.3. Emerging markets to offer high-growth opportunities for market participants
4.2. Market Restraints & Challenges
4.2.1. High risk of complications and product withdrawals, failures
4.2.2. Presence of substitutes
CHAPTER 5 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD
MARKET – BY MATERIAL
5.1. Bioresorbable Metallic Stents
5.2. Bioresorbable Polymer-Based Stents
CHAPTER 6 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD
MARKET – BY ABSORPTION RATE
6.1. Fast-Absorption Stents
6.2. Slow-Absorption Stents
CHAPTER 7 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD
MARKET – BY APPLICATION
7.1. Peripheral Artery Disease
7.2. Coronary Artery Disease
CHAPTER 8 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD
MARKET – BY END USER
8.1. Cardiac Centers
8.2. Hospitals
8.3. Others
CHAPTER 9 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD
MARKET – BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD
MARKET-COMPANY PROFILES
10.1. Amaranth Medical, Inc.
10.2. Arterial Remodeling Technologies S.A.
10.3. Meril Life Sciences Pvt. Ltd.
10.4. Arterius, Ltd.
10.5. Lepu Medical Technology Co., Ltd.
10.6 Boston Scientific Corporation
10.7. 480 Biomedical, Inc.
10.8. OrbusNeich Medical Company, Ltd.
10.9. S3V Vascular Technologies, Pvt. Ltd.
10.10. Q3 Medical Group
10.11. Abbott Laboratories, Inc.
10.12. REVA Medical, Inc.
10.13. Elixir Medical Corporation
10.14. Kyoto Medical Planning Co., Ltd.
10.15. KG Biotronik
CHAPTER 11 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD
MARKET- COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
